47045-NPL-Z-MOH-1 The Global Fund to Fight AIDS, Tuberculosis and Malaria <narrative>The Ministry of Health and Population battles against the burden of three disease with the support of its community - Nepal (01-Feb-2025-15-Jul-2027)</narrative> Nepal, Multicomponent, Ministry of Health and Food Safety of Nepal Goals: Accelerate Nepal's HIV response to achieve zero new infections, zero AIDS-related deaths, and eliminate HIV inequalities by 2030, as per NHSP 2021-2026; Nepal has set a goal to decrease incidence rate from 238 in 2020/21 to 181 per 100,000 population by 2025/26; decrease mortality rate from 58 in 2020/21 to 23 per 100,000 by 2025/26; end TB epidemic by 2035; eliminate TB by 2050; and reduce the catastrophic cost to zero; Reduce the indigenous malaria cases to zero by 2026 and sustain thereafter; Sustain zero malaria mortality. Objectives: Increase access to people-centered services across the HIV prevention and care continuum; Optimize health outcomes for people living with HIV and key populations; Strengthen community and health system resilience to reduce barriers to HIV prevention, treatment and care; To build and strengthen political commitment, sustainability and patient-friendly health system to end TB; To ensure the identification of TB, diagnosis, quality treatment and prevention; To ensure proportional and equitable access to quality assured diagnosis and treatment in health facilities as per federal structure and implement effective preventive measures to achieve malaria elimination. The Global Fund to Fight AIDS, Tuberculosis and Malaria Ministry of Health and Food Safety of Nepal Ministry of Health and Food Safety of Nepal The Global Fund to Fight AIDS, Tuberculosis and Malaria The Global Fund to Fight AIDS, Tuberculosis and Malaria Communications +41 58 791 1700 website@theglobalfund.org https://www.theglobalfund.org The Global Fund to Fight AIDS, Tuberculosis and Malaria, Global Health Campus, Chemin du Pommier 40, 1218 Grand-Saconnex, Geneva, Switzerland The Global Fund to Fight AIDS, Tuberculosis and Malaria Grant Management Division Manab Basnet Fund Portfolio Manager +41 58 791 1700 manab.basnet@theglobalfund.org https://www.theglobalfund.org The Global Fund to Fight AIDS, Tuberculosis and Malaria, Global Health Campus, Chemin du Pommier 40, 1218 Grand-Saconnex, Geneva, Switzerland Nepal Multicomponent, RSSH Malaria HIV Tuberculosis Ensure healthy lives and promote well-being for all at all ages End the epidemics of AIDS, tuberculosis, malaria and neglected tropical diseases, and combat hepatitis, water-borne diseases and other communicable diseases Achieve universal health coverage HIV -> Prevention package for other vulnerable populations (OVP) -> HIV prevention communication, information and demand creation for OVP HIV -> Reducing human rights-related barriers to HIV/TB services -> Eliminating stigma and discrimination in all settings HIV -> Reducing human rights-related barriers to HIV/TB services -> Ensuring nondiscriminatory provision of health care HIV -> Treatment, care and support -> HIV treatment and differentiated service delivery - adults (15 and above) Malaria -> Case management -> Facility-based treatment Malaria -> Case management -> Integrated community case management (iCCM) Malaria -> Case management -> Intensified activities for elimination Malaria -> Case management -> Therapeutic efficacy surveillance Malaria -> Vector control -> Entomological monitoring Malaria -> Vector control -> Indoor residual spraying (IRS) Malaria -> Vector control -> Insecticide treated nets (ITNs) - Mass campaign: universal Multicomponent -> Program management -> Coordination and management of national disease control programs Multicomponent -> Program management -> Grant management RSSH -> RSSH/PP: Laboratory systems (including national and peripheral) -> RSSH/PP: Biosafety and biosecurity, infrastructure and equipment RSSH -> RSSH/PP: Laboratory systems (including national and peripheral) -> RSSH/PP: Laboratory Information systems RSSH -> RSSH/PP: Laboratory systems (including national and peripheral) -> RSSH/PP: National laboratory governance and management structures RSSH -> RSSH/PP: Laboratory systems (including national and peripheral) -> RSSH/PP: Quality management systems and accreditation RSSH -> RSSH/PP: Laboratory systems (including national and peripheral) -> RSSH/PP: Specimen referral and transport system RSSH -> RSSH: Community systems strengthening -> Community-led monitoring RSSH -> RSSH: Health financing systems -> Health financing strategies and planning RSSH -> RSSH: Health financing systems -> Routine financial management systems RSSH -> RSSH: Health financing systems -> Social contracting RSSH -> RSSH: Health products management systems -> Planning and procurement capacity RSSH -> RSSH: Health products management systems -> Supply chain information systems RSSH -> RSSH: Monitoring and evaluation systems -> Analyses, evaluations, reviews and data use RSSH -> RSSH: Monitoring and evaluation systems -> Data quality RSSH -> RSSH: Monitoring and evaluation systems -> RSSH/PP: Surveillance for priority epidemic-prone diseases and events RSSH -> RSSH: Monitoring and evaluation systems -> Routine reporting RSSH -> RSSH: Monitoring and evaluation systems -> Surveillance for HIV, tuberculosis and malaria Tuberculosis -> Collaboration with other providers and sectors -> Collaboration with other programs/sectors Tuberculosis -> Collaboration with other providers and sectors -> Private provider engagement in TB/DR-TB care Tuberculosis -> Drug-resistant (DR)-TB diagnosis, treatment and care -> DR-TB treatment, care and support Tuberculosis -> Key and vulnerable populations (KVP) - TB/DR-TB -> KVP - Children and adolescents Tuberculosis -> Key and vulnerable populations (KVP) - TB/DR-TB -> KVP - People in prisons/jails/detention centers Tuberculosis -> TB/DR-TB Prevention -> Preventive treatment Tuberculosis -> TB/DR-TB Prevention -> Screening/testing for TB infection Tuberculosis -> TB/HIV -> TB/HIV - Collaborative interventions 1384957.15 1524243.95 1594859.00 Global Fund commitment to NPL-Z-MOHP01. The Global Fund to Fight AIDS, Tuberculosis and Malaria Ministry of Health and Food Safety of Nepal 410459.00 Global Fund disbursement to NPL-Z-MOHP01 (Government). The Global Fund to Fight AIDS, Tuberculosis and Malaria Ministry of Health and Food Safety of Nepal 390000.00 Global Fund disbursement to NPL-Z-MOHP01 (Government). The Global Fund to Fight AIDS, Tuberculosis and Malaria Ministry of Health and Food Safety of Nepal 794400.00 Global Fund disbursement to NPL-Z-MOHP01 (Government). The Global Fund to Fight AIDS, Tuberculosis and Malaria Ministry of Health and Food Safety of Nepal 765119.00 Global Fund commitment to NPL-Z-MOHP01. The Global Fund to Fight AIDS, Tuberculosis and Malaria Ministry of Health and Food Safety of Nepal <narrative>Grant page on the data explorer of the Global Fund.</narrative> An overview of a grant over its lifetime. <narrative>Grant terms and conditions.</narrative> General terms and conditions which apply to Global Fund grants. <narrative>2024 - Funding Request - Window 5 - Tuberculosis - Nepal - English</narrative> Funding Request of funding request FR1426-NPL-T. <narrative>2023 - Funding Request - Window 3 - Malaria - Nepal - English</narrative> Funding Request of funding request FR1427-NPL-M. <narrative>2024 - Funding Request - Window 5 - HIV - Nepal - English</narrative> Funding Request of funding request FR1425-NPL-H. <narrative>Percentage of confirmed cases fully investigated and classified as per national guidance</narrative> Module: Case management. <narrative>Percentage of confirmed cases fully investigated and classified as per national guidance</narrative> Geographic coverage: National, 100% of national program target. Aggregation: Non cumulative. Numerator: 586; Denominator: 665. Numerator: 370; Denominator: 370. Numerator: 445; Denominator: 445. Numerator: 872; Denominator: 872. Numerator: 427; Denominator: 427. Numerator: 427; Denominator: 427. Numerator: 466; Denominator: 466. <narrative>Percentage of districts achieving national target for the proportion of confirmed malaria patients who received first-line antimalarial treatment</narrative> Module: Case management. <narrative>Percentage of districts achieving national target for the proportion of confirmed malaria patients who received first-line antimalarial treatment</narrative> Geographic coverage: National, 100% of national program target. Aggregation: Non cumulative. Numerator: 60; Denominator: 60. Numerator: 58; Denominator: 58. Numerator: 58; Denominator: 58. Numerator: 114; Denominator: 114. Numerator: 56; Denominator: 56. Numerator: 56; Denominator: 56. Numerator: 55; Denominator: 55. <narrative>Percentage of districts achieving national target for the proportion of suspected malaria patients who receive a parasitological test</narrative> Module: Case management. <narrative>Percentage of districts achieving national target for the proportion of suspected malaria patients who receive a parasitological test</narrative> Geographic coverage: National, 100% of national program target. Aggregation: Non cumulative. Numerator: 21; Denominator: 77. Numerator: 35; Denominator: 77. Numerator: 80; Denominator: 154. Numerator: 35; Denominator: 77. Numerator: 45; Denominator: 77. Numerator: 45; Denominator: 77. Numerator: 55; Denominator: 77. <narrative>Percentage of malaria foci fully investigated and classified as per the national guidance</narrative> Module: Case management. <narrative>Percentage of malaria foci fully investigated and classified as per the national guidance</narrative> Geographic coverage: National, 100% of national program target. Aggregation: Non cumulative. Numerator: 16; Denominator: 16; Percentage: 100%. Numerator: 4; Denominator: 4; Percentage: 100%. Numerator: 5; Denominator: 5. Numerator: 5; Denominator: 5; Percentage: 100%. Numerator: 0. Numerator: 0. Numerator: 0. <narrative>Proportion of confirmed malaria cases that received first-line antimalarial treatment at private sector sites</narrative> Module: Case management. <narrative>Proportion of confirmed malaria cases that received first-line antimalarial treatment at private sector sites</narrative> Geographic coverage: National, 100% of national program target. Aggregation: Non cumulative. Numerator: 94; Denominator: 94; Percentage: 100%. Numerator: 16; Denominator: 16; Percentage: 100%. Numerator: 570; Denominator: 649; Percentage: 87.83%. Numerator: 55; Denominator: 55; Percentage: 100%. Numerator: 66; Denominator: 66; Percentage: 100%. Numerator: 130; Denominator: 130; Percentage: 100%. Numerator: 64; Denominator: 64; Percentage: 100%. Numerator: 40; Denominator: 40; Percentage: 100%. Numerator: 0; Denominator: 0. Numerator: 64; Denominator: 64; Percentage: 100%. Numerator: 69; Denominator: 69; Percentage: 100%. <narrative>Proportion of confirmed malaria cases that received first-line antimalarial treatment at public sector health facilities</narrative> Module: Case management. <narrative>Proportion of confirmed malaria cases that received first-line antimalarial treatment at public sector health facilities</narrative> Geographic coverage: Subnational, 100% of national program target. Aggregation: Non cumulative. Numerator: 542; Denominator: 542. Numerator: 28; Denominator: 28. Numerator: 1; Denominator: 1. Numerator: 296.25; Denominator: 296.25. Numerator: 355.5; Denominator: 355.5. Numerator: 693.5; Denominator: 693.5. Numerator: 338; Denominator: 338. Numerator: 1; Denominator: 1. Numerator: 458; Denominator: 458. Numerator: 338; Denominator: 338. Numerator: 371; Denominator: 371. <narrative>Proportion of confirmed malaria cases that received first-line antimalarial treatment in the community</narrative> Module: Case management. <narrative>Proportion of confirmed malaria cases that received first-line antimalarial treatment in the community</narrative> Geographic coverage: Subnational, 100% of national program target. Aggregation: Non cumulative. Numerator: 29; Denominator: 29; Percentage: 100%. Numerator: 93; Denominator: 93; Percentage: 100%. Numerator: 1; Denominator: 1; Percentage: 100%. Numerator: 20; Denominator: 20; Percentage: 100%. Numerator: 49; Denominator: 49; Percentage: 100%. Numerator: 24; Denominator: 24; Percentage: 100%. Numerator: 25; Denominator: 25; Percentage: 100%. Numerator: 13; Denominator: 13; Percentage: 100%. Numerator: 0; Denominator: 0. Numerator: 25; Denominator: 25; Percentage: 100%. Numerator: 26; Denominator: 26; Percentage: 100%. <narrative>Proportion of suspected malaria cases that receive a parasitological test at private sector sites</narrative> Module: Case management. <narrative>Proportion of suspected malaria cases that receive a parasitological test at private sector sites</narrative> Geographic coverage: National, 100% of national program target. Aggregation: Non cumulative. Numerator: 122998; Denominator: 122998; Percentage: 100%. Numerator: 2; Denominator: 2; Percentage: 100%. Numerator: 81489; Denominator: 81489; Percentage: 100%. Numerator: 97786.81; Denominator: 97786.81; Percentage: 100%. Numerator: 175166.9; Denominator: 175166.9; Percentage: 100%. Numerator: 77380.15; Denominator: 77380.15; Percentage: 100%. Numerator: 33432. Numerator: 116070.22; Denominator: 116070.22; Percentage: 100%. Numerator: 111575.05; Denominator: 111575.05; Percentage: 100%. <narrative>Proportion of suspected malaria cases that receive a parasitological test at public sector health facilities</narrative> Module: Case management. <narrative>Proportion of suspected malaria cases that receive a parasitological test at public sector health facilities</narrative> Geographic coverage: Subnational, 100% of national program target. Aggregation: Non cumulative. Numerator: 278546; Denominator: 278546; Percentage: 100%. Numerator: 66440; Denominator: 66440; Percentage: 100%. Numerator: 203261.2; Denominator: 203261.2; Percentage: 100%. Numerator: 442094.6; Denominator: 442094.6; Percentage: 100%. Numerator: 243913.44; Denominator: 243913.44; Percentage: 100%. Numerator: 198181.16; Denominator: 198181.16; Percentage: 100%. Numerator: 89227. Numerator: 297271.74; Denominator: 297271.74; Percentage: 100%. Numerator: 293520.47; Denominator: 293520.47; Percentage: 100%. <narrative>Proportion of suspected malaria cases that receive a parasitological test in the community</narrative> Module: Case management. <narrative>Proportion of suspected malaria cases that receive a parasitological test in the community</narrative> Geographic coverage: Subnational, 100% of national program target. Aggregation: Non cumulative. Numerator: 66440; Denominator: 66440; Percentage: 100%. Numerator: 43049. Numerator: 79949; Denominator: 79949; Percentage: 100%. Numerator: 39146.16; Denominator: 39146.16; Percentage: 100%. Numerator: 46975.39; Denominator: 46975.39; Percentage: 100%. Numerator: 85215.3; Denominator: 85215.3; Percentage: 100%. Numerator: 38239.85; Denominator: 38239.85; Percentage: 100%. Numerator: 0. Numerator: 16122. Numerator: 57359.78; Denominator: 57359.78; Percentage: 100%. Numerator: 56741.34; Denominator: 56741.34; Percentage: 100%. <narrative>Percentage of people newly diagnosed with HIV initiated on ART</narrative> Module: Differentiated HIV Testing Services. <narrative>Percentage of people newly diagnosed with HIV initiated on ART</narrative> Geographic coverage: National, 100% of national program target. Aggregation: Non cumulative. Numerator: 2416; Denominator: 2570. Numerator: 841; Denominator: 885. Numerator: 841; Denominator: 885. Numerator: 841; Denominator: 885. Numerator: 652; Denominator: 686. <narrative>Number of people with confirmed RR-TB and/or MDR-TB notified</narrative> Module: Drug-resistant (DR)-TB diagnosis, treatment and care. <narrative>Number of people with confirmed RR-TB and/or MDR-TB notified</narrative> Geographic coverage: National, 100% of national program target. Aggregation: Non cumulative. <narrative>Percentage of people with confirmed RR-TB and/or MDR-TB that began second-line treatment</narrative> Module: Drug-resistant (DR)-TB diagnosis, treatment and care. <narrative>Percentage of people with confirmed RR-TB and/or MDR-TB that began second-line treatment</narrative> Geographic coverage: National, 100% of national program target. Aggregation: Non cumulative. Numerator: 546; Denominator: 693. Numerator: 398; Denominator: 468. Numerator: 1070; Denominator: 1223. Numerator: 510; Denominator: 601. Numerator: 560; Denominator: 622. Numerator: 774; Denominator: 860. Numerator: 774; Denominator: 860. <narrative>Treatment success rate of RR-TB and/or MDR-TB: Percentage of patients with RR and/or MDR-TB successfully treated</narrative> Module: Drug-resistant (DR)-TB diagnosis, treatment and care. <narrative>Treatment success rate of RR-TB and/or MDR-TB: Percentage of patients with RR and/or MDR-TB successfully treated</narrative> Geographic coverage: National, 100% of national program target. Aggregation: Non cumulative. Numerator: 305; Denominator: 396. Numerator: 224; Denominator: 273. Numerator: 229; Denominator: 279. Numerator: 493; Denominator: 590. Numerator: 264; Denominator: 311. Numerator: 285; Denominator: 335. Numerator: 285; Denominator: 335. <narrative>Percentage of HIV-exposed infants receiving a virological test for HIV within 2 months of birth</narrative> Module: Elimination of vertical transmission of HIV, syphilis and hepatitis B. <narrative>Percentage of HIV-exposed infants receiving a virological test for HIV within 2 months of birth</narrative> Geographic coverage: National, 100% of national program target. Aggregation: Non cumulative - special. Numerator: 2037.07. Numerator: 0. Numerator: 27063.93. Numerator: 153; Denominator: 214; Percentage: 71.5%. Numerator: 83; Denominator: 190; Percentage: 43.68%. Numerator: 83; Denominator: 190; Percentage: 43.68%. Numerator: 169; Denominator: 181; Percentage: 93.4%. Numerator: 86; Denominator: 181; Percentage: 47.51%. Numerator: 63. Numerator: 1. Numerator: 0. Numerator: 86; Denominator: 181; Percentage: 47.51%. Numerator: 82; Denominator: 172; Percentage: 47.67%. <narrative>Percentage of laboratories accredited according to ISO15189 standard or achieving at least four stars towards accreditation or two-star incremental improvement</narrative> Module: RSSH/PP: Laboratory systems (including national and peripheral). <narrative>Percentage of laboratories accredited according to ISO15189 standard or achieving at least four stars towards accreditation or two-star incremental improvement</narrative> Geographic coverage: National, 100% of national program target. Aggregation: Non cumulative - other. Numerator: 1; Denominator: 6. Numerator: 1; Denominator: 6. Numerator: 2; Denominator: 6. Numerator: 3; Denominator: 6. Numerator: 3; Denominator: 6. Numerator: 4; Denominator: 6. Numerator: 6; Denominator: 6. <narrative>Percentage of molecular diagnostic analyzers achieving at least 85% functionality (ability to test samples) during the reporting period</narrative> Module: RSSH/PP: Laboratory systems (including national and peripheral). <narrative>Percentage of molecular diagnostic analyzers achieving at least 85% functionality (ability to test samples) during the reporting period</narrative> Geographic coverage: National, 100% of national program target. Aggregation: Non cumulative - other. Numerator: 130; Denominator: 145. Numerator: 130; Denominator: 145. Numerator: 135; Denominator: 150. Numerator: 508; Denominator: 535. Numerator: 508; Denominator: 535. Numerator: 508; Denominator: 535. Numerator: 508; Denominator: 535. <narrative>Completeness of reporting: Percentage of expected monthly reports (for the reporting period) that are actually received</narrative> Module: RSSH: Monitoring and evaluation systems. <narrative>Completeness of reporting: Percentage of expected monthly reports (for the reporting period) that are actually received</narrative> Geographic coverage: National, 100% of national program target. Aggregation: Non cumulative. Numerator: 172; Denominator: 172. <narrative>Timeliness of reporting: Percentage of submitted monthly reports (for the reporting period) that are received on time per the national guidelines</narrative> Module: RSSH: Monitoring and evaluation systems. <narrative>Timeliness of reporting: Percentage of submitted monthly reports (for the reporting period) that are received on time per the national guidelines</narrative> Geographic coverage: National, 100% of national program target. Aggregation: Non cumulative. <narrative>Number of patients with of all forms of TB notified (i.e., bacteriologically confirmed + clinically diagnosed); *includes only those with new and relapse TB</narrative> Module: TB diagnosis, treatment and care. <narrative>Number of patients with of all forms of TB notified (i.e., bacteriologically confirmed + clinically diagnosed); *includes only those with new and relapse TB</narrative> Geographic coverage: National, 100% of national program target. Aggregation: Non cumulative. Numerator: 27063.93. Numerator: 0. Numerator: 27729; Denominator: 30125; Percentage: 92.05%. Numerator: 1372; Denominator: 3347; Percentage: 40.99%. Numerator: 2037.07. Numerator: 40128. Numerator: 22181. Numerator: 47997. Numerator: 23907. Numerator: 24090. Numerator: 20230. Numerator: 1355. Numerator: 13175. Numerator: 20712. Numerator: 774. Numerator: 26103. Numerator: 26103. <narrative>Percentage of new and relapse TB patients tested using WHO recommended rapid diagnostic tests at the time of diagnosis</narrative> Module: TB diagnosis, treatment and care. <narrative>Percentage of new and relapse TB patients tested using WHO recommended rapid diagnostic tests at the time of diagnosis</narrative> Geographic coverage: National, 100% of national program target. Aggregation: Non cumulative. Numerator: 11947; Denominator: 23425. Numerator: 13309; Denominator: 22181. Numerator: 15540; Denominator: 23907. Numerator: 31199; Denominator: 47997. Numerator: 15659; Denominator: 24090. Numerator: 18272; Denominator: 26103. Numerator: 18272; Denominator: 26103. <narrative>Percentage of notified patients with all forms of TB (i.e., bacteriologically confirmed + clinically diagnosed) contributed by non-national TB program providers- private/non-governmental facilities; *includes only those with new and relapse TB</narrative> Module: TB diagnosis, treatment and care. <narrative>Percentage of notified patients with all forms of TB (i.e., bacteriologically confirmed + clinically diagnosed) contributed by non-national TB program providers- private/non-governmental facilities; *includes only those with new and relapse TB</narrative> Geographic coverage: National, 100% of national program target. Aggregation: Non cumulative. Numerator: 51835.8. Numerator: 10963; Denominator: 40126; Percentage: 27.32%. Numerator: 6654; Denominator: 22181; Percentage: 30%. Numerator: 7172; Denominator: 23907; Percentage: 30%. Numerator: 14399; Denominator: 47997; Percentage: 30%. Numerator: 7227; Denominator: 24090; Percentage: 30%. Numerator: 2060. Numerator: 7831; Denominator: 26103; Percentage: 30%. Numerator: 7831; Denominator: 26103; Percentage: 30%. <narrative>Treatment success rate- all forms: Percentage of patients with all forms of TB, bacteriologically confirmed plus clinically diagnosed, successfully treated (cured plus treatment completed) among all TB patients notified during a specified period; *includes only those with new and relapse TB</narrative> Module: TB diagnosis, treatment and care. <narrative>Treatment success rate- all forms: Percentage of patients with all forms of TB, bacteriologically confirmed plus clinically diagnosed, successfully treated (cured plus treatment completed) among all TB patients notified during a specified period; *includes only those with new and relapse TB</narrative> Geographic coverage: National, 100% of national program target. Aggregation: Non cumulative. Numerator: 34410; Denominator: 37003. Numerator: 21863; Denominator: 23764. Numerator: 41555; Denominator: 45169. Numerator: 21149; Denominator: 22988. Numerator: 20406; Denominator: 22181. Numerator: 21995; Denominator: 23907. Numerator: 22163; Denominator: 24090. <narrative>Number of people in contact with TB patients who began preventive therapy</narrative> Module: TB/DR-TB Prevention. <narrative>Number of people in contact with TB patients who began preventive therapy</narrative> Geographic coverage: National, 100% of national program target. Aggregation: Non cumulative. <narrative>Percentage of HIV-positive new and relapse TB patients on ART during TB treatment</narrative> Module: TB/HIV. <narrative>Percentage of HIV-positive new and relapse TB patients on ART during TB treatment</narrative> Geographic coverage: National, 100% of national program target. Aggregation: Non cumulative. Numerator: 205; Denominator: 208. Numerator: 249; Denominator: 254. Numerator: 247; Denominator: 252. Numerator: 508; Denominator: 518. Numerator: 261; Denominator: 266. Numerator: 258.72; Denominator: 264. Numerator: 259; Denominator: 264. <narrative>Percentage of people living with HIV currently enrolled on antiretroviral therapy who started TB preventive treatment (TPT) during the reporting period</narrative> Module: TB/HIV. <narrative>Percentage of people living with HIV currently enrolled on antiretroviral therapy who started TB preventive treatment (TPT) during the reporting period</narrative> Geographic coverage: Subnational, less than 100% national program target. Aggregation: Non cumulative - special. Numerator: 5513; Denominator: 22421; Percentage: 24.59%. Numerator: 7576; Denominator: 25728; Percentage: 29.45%. Numerator: 10443; Denominator: 26374; Percentage: 39.6%. Numerator: 11903; Denominator: 26704; Percentage: 44.57%. Numerator: 25336; Denominator: 27039; Percentage: 93.7%. Numerator: 13433; Denominator: 27039; Percentage: 49.68%. Numerator: 11824. Numerator: 14963; Denominator: 27375; Percentage: 54.66%. Numerator: 16348; Denominator: 27381; Percentage: 59.71%. <narrative>Percentage of people living with HIV newly initiated on ART who were screened for TB</narrative> Module: TB/HIV. <narrative>Percentage of people living with HIV newly initiated on ART who were screened for TB</narrative> Geographic coverage: National, 100% of national program target. Aggregation: Non cumulative. Numerator: 430237.14. Numerator: 36285.06. Numerator: 51835.8. Numerator: 1500; Denominator: 1500; Percentage: 100%. Percentage: 100%. Percentage: 100%. Percentage: 100%. Percentage: 100%. Numerator: 1092. Numerator: 20. Numerator: 682. Percentage: 100%. Percentage: 100%. <narrative>Percentage of registered new and relapse TB patients with documented HIV status</narrative> Module: TB/HIV. <narrative>Percentage of registered new and relapse TB patients with documented HIV status</narrative> Geographic coverage: National, 100% of national program target. Aggregation: Non cumulative. Numerator: 33192.9; Denominator: 36881. Numerator: 31688; Denominator: 33356. Numerator: 64736; Denominator: 66396. Numerator: 31545; Denominator: 33205. Numerator: 33191; Denominator: 33191. Numerator: 33041; Denominator: 33041. Numerator: 33041; Denominator: 33041. <narrative>Percentage of children (under 15) on ART among all children living with HIV at the end of the reporting period</narrative> Module: Treatment, care and support. <narrative>Percentage of children (under 15) on ART among all children living with HIV at the end of the reporting period</narrative> Geographic coverage: National, 100% of national program target. Aggregation: Non cumulative - other. Numerator: 7004. Numerator: 18245. Numerator: 945; Denominator: 1097; Percentage: 86.14%. Numerator: 945; Denominator: 1018; Percentage: 92.83%. Numerator: 932; Denominator: 972; Percentage: 95.9%. Numerator: 953; Denominator: 1018; Percentage: 93.61%. Numerator: 932; Denominator: 972; Percentage: 95.88%. Numerator: 352; Denominator: 490; Percentage: 71.84%. Numerator: 407; Denominator: 512; Percentage: 79.49%. Numerator: 910; Denominator: 972; Percentage: 93.62%. Numerator: 890; Denominator: 923; Percentage: 96.42%. <narrative>Percentage of people living with HIV and currently on antiretroviral therapy who are receiving multi month dispensing of antiretroviral medicine</narrative> Module: Treatment, care and support. <narrative>Percentage of people living with HIV and currently on antiretroviral therapy who are receiving multi month dispensing of antiretroviral medicine</narrative> Geographic coverage: National, 100% of national program target. Aggregation: Non cumulative - other. Numerator: 6024; Denominator: 25728. Numerator: 7578; Denominator: 27039. Numerator: 7578; Denominator: 27039. Numerator: 8212; Denominator: 27375. Numerator: 9586; Denominator: 27381. <narrative>Percentage of people on ART among all people living with HIV at the end of the reporting period</narrative> Module: Treatment, care and support. <narrative>Percentage of people on ART among all people living with HIV at the end of the reporting period</narrative> Geographic coverage: National, 100% of national program target. Aggregation: Non cumulative - other. Numerator: 25728; Denominator: 30302. Numerator: 26374; Denominator: 30311. Numerator: 27039; Denominator: 30332. Numerator: 26704; Denominator: 30311. Numerator: 27039; Denominator: 30332. Numerator: 27375; Denominator: 30332. Numerator: 27381; Denominator: 30347. <narrative>Percentage of pregnant women living with HIV who received antiretroviral medicine to reduce the risk of vertical transmission of HIV</narrative> Module: Treatment, care and support. <narrative>Percentage of pregnant women living with HIV who received antiretroviral medicine to reduce the risk of vertical transmission of HIV</narrative> Geographic coverage: Subnational, less than 100% national program target. Aggregation: Non cumulative - special. Numerator: 165; Denominator: 214. Numerator: 86; Denominator: 95. Numerator: 172; Denominator: 90.5. Numerator: 86; Denominator: 95. Numerator: 86; Denominator: 90.5. Numerator: 86; Denominator: 90.5. Numerator: 82; Denominator: 86. <narrative>Number of insecticide-treated nets distributed to populations at risk of malaria transmission through mass campaigns</narrative> Module: Vector control. <narrative>Number of insecticide-treated nets distributed to populations at risk of malaria transmission through mass campaigns</narrative> Geographic coverage: Subnational, 100% of national program target. Aggregation: Non cumulative. <narrative>Number of insecticide-treated nets distributed to targeted risk groups through continuous distribution</narrative> Module: Vector control. <narrative>Number of insecticide-treated nets distributed to targeted risk groups through continuous distribution</narrative> Geographic coverage: National, 100% of national program target. Aggregation: Non cumulative.